Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07244978 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07244978
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.